{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:39:47Z","timestamp":1774877987978,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    We report on the successful management of severe immune reconstitution inflammatory syndrome (IRIS) in a 28-year-old Indonesian male with advanced HIV\/AIDS, complicated by disseminated histoplasmosis. This case highlights the clinical challenges and innovative approaches in treating severe IRIS, where conventional management strategies proved inadequate. The patient presented with progressive clinical deterioration briefly after initiation of antiretroviral therapy (ART). Disseminated histoplasmosis was suspected based on clinical and radiographic findings and later confirmed as the underlying infectious trigger of IRIS, guiding targeted therapeutic strategies. Clinical management involved the novel use of a Janus kinase (JAK) inhibitor and a cytokine adsorption filter (CytoSorb\n                    <jats:sup>\u00ae<\/jats:sup>\n                    ), alongside escalated antifungal and immunosuppressive therapies. This multifaceted approach not only stabilized the patient\u2019s condition but also highlighted the importance of considering advanced therapeutic options in severe IRIS cases. The use of JAK inhibition in this context provides new insights into the modulation of immune responses in IRIS, while cytokine adsorption therapy offered a method to control the systemic inflammatory response that characterizes this condition. This case underscores the critical need for awareness of uncommon pathogens like Histoplasma in IRIS and illustrates the potential for integrating novel therapeutic modalities to improve outcomes in these complex scenarios. Our experience suggests that early consideration of advanced immunomodulatory therapies should be considered in severe IRIS cases refractory to standard treatments.\n                  <\/jats:p>","DOI":"10.1186\/s12981-025-00819-4","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:28:21Z","timestamp":1763537301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful management of severe IRIS associated with disseminated histoplasmosis in an HIV patient using cytokine adsorption therapy and JAK inhibition"],"prefix":"10.1186","volume":"22","author":[{"given":"Micha","family":"Banz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Schleenvoigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Baier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunja","family":"Wilmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Dudziak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","unstructured":"Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel Fran\u00e7ois, Huerre M, Olivier Lortholary. Fran\u00e7oise Dromer, Bertrand Dupont, and. 2006. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 20. Lippincott Williams and Wilkins: 119\u2013121. https:\/\/doi.org\/10.1097\/01.AIDS.0000199014.66139.39","DOI":"10.1097\/01.AIDS.0000199014.66139.39"},{"key":"819_CR2","unstructured":"1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. 2024. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00018871.htm. Accessed December 14."},{"key":"819_CR3","unstructured":"Brust JCM, Joseph P, Mcgowan SM, Fine ST, Merrick AE, Radix RM, Vail B, Norton CJ, Gonzalez, Christopher JH. 2017. Management of immune reconstitution inflammatory syndrome (IRIS) Updates, Authorship, and related guidelines MEDICAL CARE CRITERIA COMMITTEE management of immune reconstitution inflammatory syndrome (IRIS). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570544\/pdf\/Bookshelf_NBK570544.pdf"},{"key":"819_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","author":"J Henter","year":"2007","unstructured":"Henter J, Inge AC, Horne M, Aric\u00f3 R, Maarten Egeler AH, Filipovich S, Imashuku S, Ladisch, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric blood and cancer. Pediatr Blood Cancer. 2007. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"key":"819_CR5","doi-asserted-by":"publisher","unstructured":"Becker S\u00f6ren, Lang H, Barbosa CV, Tian Z, Melk A, Bernhard MW, Schmidt. 2023. Efficacy of CytoSorb\u00ae: a systematic review and meta-analysis. Critical care (London, England) 27. Crit Care. https:\/\/doi.org\/10.1186\/S13054-023-04492-9","DOI":"10.1186\/S13054-023-04492-9"},{"key":"819_CR6","doi-asserted-by":"publisher","unstructured":"Melzani A, Michel RDRDS, Ntab B, Djossou F, Epelboin L, Nacher M, Blanchet D, Demar M, Couppie P, and Antoine Adenis. 2020. IncidenceTrends in Immune Reconstitution Inflammatory Syndrome Associated with Histoplasma capsulatum among People Living with Human Immunodeficiency Virus: A 20-Year Case SeriesLiterature Review. Clinical Infectious Diseases 70. Oxford Academic: 643\u2013652. https:\/\/doi.org\/10.1093\/cid\/ciz247","DOI":"10.1093\/cid\/ciz247"},{"key":"819_CR7","doi-asserted-by":"publisher","unstructured":"Clezar I, Vasconcellos S, Flores D, Lana D, Pasqualotto AC. and Dom Vicente Scherer. 2019. The Role of Molecular Tests in the Diagnosis of Disseminated Histoplasmosis. Journal of Fungi 2020, Vol. 6, Page 1 6. Multidisciplinary Digital Publishing Institute: 1. https:\/\/doi.org\/10.3390\/JOF6010001","DOI":"10.3390\/JOF6010001"},{"key":"819_CR8","doi-asserted-by":"publisher","unstructured":"Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel Fran\u00e7ois, Huerre M, Dromer Fran\u00e7oise, Dupont B, and Olivier Lortholary. 2006. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS (London, England) 20. AIDS: 119\u2013121. https:\/\/doi.org\/10.1097\/01.AIDS.0000199014.66139.39","DOI":"10.1097\/01.AIDS.0000199014.66139.39"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","volume":"10","author":"LJ Haddow","year":"2010","unstructured":"Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Julian H, Elliott YC, Manabe PR, Bohjanen, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1\u2013infected individuals: literature review and proposed clinical case definitions. Lancet Infect Dis. 2010;10:791. https:\/\/doi.org\/10.1016\/S1473-3099(10)70170-5.","journal-title":"Lancet Infect Dis"},{"key":"819_CR10","doi-asserted-by":"publisher","unstructured":"Damsky W, Peterson D, Ramseier J, Al-Bawardy B, Chun H, Proctor D, Strand V, Flavell RA, King B. 2021. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. The Journal of allergy and clinical immunology 147. J Allergy Clin Immunol: 814\u2013826. https:\/\/doi.org\/10.1016\/J.JACI.2020.10.022","DOI":"10.1016\/J.JACI.2020.10.022"},{"key":"819_CR11","doi-asserted-by":"publisher","unstructured":"Kerschbaumer A, Smolen JS, Nash P, Doerner T, Dougados M, Fleischmann R, Geissler K et al. 2020. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD Open 6. BMJ Publishing Group: e001374. https:\/\/doi.org\/10.1136\/RMDOPEN-2020-001374","DOI":"10.1136\/RMDOPEN-2020-001374"},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"794","DOI":"10.61186\/UMJ.34.12.794","volume":"34","author":"V Hashemi","year":"2024","unstructured":"Hashemi V, Ahmadpour M, Mehranfar S, Haris RS, Arezou Hoseini. Janus kinase inhibitors: A new therapeutic option for autoimmune diseases. Stud Med Sci. 2024;34:794\u2013815. https:\/\/doi.org\/10.61186\/UMJ.34.12.794. Studies in Medical Sciences.","journal-title":"Stud Med Sci"},{"key":"819_CR13","doi-asserted-by":"publisher","unstructured":"Bindra BS, Katherine Garcia de de Jesus O, Cisneros, Vinicius M, Jorge. and Harpreet Kaur. 2019. Hemophagocytic Lymphohistiocytosis: Management and Special Consideration in Human Immunodeficiency Virus Positive Patients with Immune Reconstitution Syndrome. Cureus 11. Springer Science and Business Media LLC: e5402. https:\/\/doi.org\/10.7759\/CUREUS.5402","DOI":"10.7759\/CUREUS.5402"},{"key":"819_CR14","doi-asserted-by":"publisher","unstructured":"Hershey J, Iris Associated HLH. Determining Appropriate Treatment Based on Underlying Etiology. American Thoracic Society International Conference Meetings Abstracts American Thoracic Society International Conference Meetings Abstracts. American Thoracic Society: A1356\u2013A1356. https:\/\/doi.org\/10.1164\/AJRCCM-CONFERENCE.2024.209.1_MEETINGABSTRACTS.A1356","DOI":"10.1164\/AJRCCM-CONFERENCE.2024.209.1_MEETINGABSTRACTS.A1356"},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/S-0040-1708479","volume":"KG","author":"A Akil","year":"2021","unstructured":"Akil A, Ziegeler S, Reichelt J, Rehers S, Abdalla O, Semik M, and Stefan Fischer. Combined use of cytosorb and ECMO in patients with severe pneumogenic sepsis. The Thorac Cardiovasc Surgeon 69 Georg Thieme Verlag. 2021;KG:246\u201351. https:\/\/doi.org\/10.1055\/S-0040-1708479.","journal-title":"The Thorac Cardiovasc Surgeon 69 Georg Thieme Verlag"},{"key":"819_CR16","doi-asserted-by":"publisher","unstructured":"Goetz G, Hawlik K, Wild C. 2021. Extracorporeal Cytokine Adsorption Therapy As a Preventive Measure in Cardiac Surgery and As a Therapeutic Add-On Treatment in Sepsis: An Updated Systematic Review of Comparative Efficacy and Safety. Critical care medicine 49. Crit Care Med: 1347\u20131357. https:\/\/doi.org\/10.1097\/CCM.0000000000005023","DOI":"10.1097\/CCM.0000000000005023"},{"key":"819_CR17","doi-asserted-by":"publisher","unstructured":"Mariano F, Greco\u2019 D, Depetris N, Mella A, Sciarrillo A, Stella M, Berardino M, Risso D, Gambino R, and Luigi Biancone. 2024. CytoSorb\u00ae in burn patients with septic shockAcute Kidney Injury on Continuous Kidney Replacement Therapy is associated with improved clinical outcomesurvival. Burns 50. Elsevier: 1213\u20131222. https:\/\/doi.org\/10.1016\/J.BURNS.2024.02.028","DOI":"10.1016\/J.BURNS.2024.02.028"},{"key":"819_CR18","doi-asserted-by":"publisher","unstructured":"Keeley AJ, Parkash V, Tunbridge A, Greig J, Collini P, McKane W, Tattersall RS. 2020. Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases. International Journal of STD and AIDS 31. SAGE Publications Ltd: 808\u2013812. https:\/\/doi.org\/10.1177\/0956462420915394\/ASSET\/IMAGES\/LARGE\/10.1177_0956462420915394-FIG2.JPEG","DOI":"10.1177\/0956462420915394\/ASSET\/IMAGES\/LARGE\/10.1177_0956462420915394-FIG2.JPEG"},{"key":"819_CR19","unstructured":"Correspondence on \u2018. Interleukin-6 receptor Blockade with subcutaneous Tocilizumab in severe COVID-19 pneumonia and hyperinflammation. case\u2013control study\u2019 | Enhanced Reader; 2024."},{"key":"819_CR20","doi-asserted-by":"publisher","unstructured":"Virtanen A, Spinelli FR, Telliez JB, John J, O\u2019Shea OS, Gadina M. 2024. JAK inhibitor selectivity: new opportunities, better drugs? Nature Reviews Rheumatology 2024 20:10 20. Nature Publishing Group: 649\u2013665. https:\/\/doi.org\/10.1038\/s41584-024-01153-1","DOI":"10.1038\/s41584-024-01153-1"},{"key":"819_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.1038354","author":"H Yan","year":"2022","unstructured":"Yan H, Mo Y, Liu S, Luo X, Liu L, Zhou L, Zhang X, Chen Y, Ke Cao. Case report: hemophagocytic lymphohistiocytosis in a child with primary immunodeficiency infected with talaromyces Marneffei. Frontiers Immunology 13 Front Immunol. 2022. https:\/\/doi.org\/10.3389\/FIMMU.2022.1038354.","journal-title":"Frontiers Immunology 13 Front Immunol"},{"key":"819_CR22","doi-asserted-by":"publisher","unstructured":"Xie YL, Ita-Nagy F, Chen RY, Manion MM, Sereti I, Pei L. and Steven M. Holland. 2019. Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With Ruxolitinib. Open Forum Infectious Diseases 6. Oxford Academic. https:\/\/doi.org\/10.1093\/OFID\/OFZ422","DOI":"10.1093\/OFID\/OFZ422"},{"key":"819_CR23","unstructured":"JAK inhibitors. new indication and emerging safety data in 2022 | Enhanced Reader. 2024."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00819-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:28:22Z","timestamp":1763537302000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00819-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00819-4","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report was obtained from the patient prior to manuscript preparation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}